Probiotics and otitis media in children

International Journal of Pediatric Otorhinolaryngology

Volumn 76, Issue 4, 2012, Pages 465-470

  Niittynen, Leena ^a   Pitkäranta, Anne ^b   Korpela, Riitta ^c  

^a Nutritionist Leena Niittynen   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Acute otitis media; Bifidobacterium; Lactobacillus; Nasopharyngeal flora; Otitis prone child

Indexed keywords

ANTIBIOTIC AGENT; PLACEBO; PROBIOTIC AGENT;

ACUTE OTITIS MEDIA; ANTIBIOTIC THERAPY; DISEASE CONTROL; HIGH RISK POPULATION; HUMAN; INFECTION RISK; LACTOBACILLUS; MILK; OTITIS MEDIA; PRIORITY JOURNAL; RECURRENT INFECTION; REVIEW; RISK REDUCTION; SECRETORY OTITIS MEDIA; STREPTOCOCCUS; SYSTEMATIC REVIEW; THERAPY EFFECT; TREATMENT DURATION; TREATMENT RESPONSE;

CHILD; CHILD, PRESCHOOL; HUMANS; INCIDENCE; INFANT, NEWBORN; OTITIS MEDIA; PROBIOTICS;

EID: 84859005188     PISSN: 01655876     EISSN: 18728464     Source Type: Journal    
DOI: 10.1016/j.ijporl.2012.01.011     Document Type: Review

References (29)

1. Food and Agriculture Organization of the United Nations and the World Health Organization, Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria, Cordoba, Argentina. , 2001. http://www.who.int/foodsafety/publications/fs_management/en/probiotics.pdf.
2. Kligler B., Cohrssen A. Probiotics. Am. Fam. Physician 2008, 78(9):1073-1078.
3. Hatakka K., Saxelin M. Probiotics in intestinal and non-intestinal infectious diseases - clinical evidence. Curr. Pharm. Des. 2008, 14(14):1351-1367.
4. Wolvers D., Antoine J.M., Myllyluoma E., Schrezenmeir J., Szajewska H., Rijkers G.T. Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of infections by probiotics. J. Nutr. 2010, 140(3):698S-712S.
5. K. Hatakka, Probiotics in the prevention of clinical manifestations of common infectious diseases in children and in the elderly, Ph.D. Thesis, Helsinki, University of Helsinki. , 2007. http://ethesis.helsinki.fi/.
6. Vergison A., Dagan R., Arguedas A., Bonhoeffer J., Cohen R., Dhooge I., et al. Otitis media and its consequences: beyond the earache. Lancet Infect. Dis. 2010, 10(3):195-203.
7. Brook I., Gober A.E. Antimicrobial resistance in the nasopharyngeal flora of children with acute otitis media and otitis media recurring after amoxicillin therapy. J. Med. Microbiol. 2005, 54(Pt 1):83-85.
8. Nord C.E., Sillerström E., Wahlund E. Effect of tigecycline on normal oropharyngeal and intestinal microflora. Antimicrob. Agents Chemother. 2006, 50(10):3375-3380.
9. Willing B.P., Russell S.L., Finlay B.B. Shifting the balance: antibiotic effects on host-microbiota mutualism. Nat. Rev. Microbiol. 2011, 9(4):233-243.
10. Hatakka K., Savilahti E., Pönkä A., Meurman J.H., Poussa T., Näse L., et al. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ 2001, 322:1327-1329.
11. Stecksén-Blicks C., Sjöström I., Twetman S. Effect of long-term consumption of milk supplemented with probiotic lactobacilli and fluoride on dental caries and general health in preschool children: a cluster-randomized study. Caries Res. 2009, 43(5):374-381.
12. Hatakka K., Blomgren K., Pohjavuori S., Kaijalainen T., Poussa T., Leinonen M., et al. Treatment of acute otitis media with probiotics in otitis-prone children - a double-blind, placebo-controlled randomised study. Clin. Nutr. 2007, 26(3):314-321.
13. Rautava S., Salminen S., Isolauri E. Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. Br. J. Nutr. 2009, 101(11):1722-1726.
14. Taipale T., Pienihäkkinen K., Isolauri E., Larsen C., Brockmann E., Alanen P., et al. Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy. Br. J. Nutr. 2011, 105(3):409-416.
15. Hojsak I., Snovak N., Abdović S., Szajewska H., Misak Z., Kolacek S. Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clin. Nutr. 2010, 29(3):312-316.
16. Roos K., Håkansson E.G., Holm S. Effect of recolonisation with " interfering" alpha streptococci on recurrences of acute and secretory otitis media in children: randomised placebo controlled trial. BMJ 2001, 322(7280):210-212.
17. Skovbjerg S., Roos K., Holm S.E., Grahn Håkansson E., Nowrouzian F., Ivarsson M. Spray bacteriotherapy decreases middle ear fluid in children with secretory otitis media. Arch. Dis. Child. 2009, 94(2):92-98.
18. Tano K., Grahn Håkansson E., Holm S.E., Hellström S. A nasal spray with alpha-haemolytic streptococci as long term prophylaxis against recurrent otitis media. Int. J. Pediatr. Otorhinolaryngol. 2002, 62(1):17-23.
19. Erickson K.L., Hubbard N.E. Probiotic immunomodulation in health and disease. J. Nutr. 2000, 130(2S Suppl.):403S-409S.
20. de Vrese M., Winkler P., Rautenberg P., Harder T., Noah C., Laue C., et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3 B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clin. Nutr. 2005, 24(4):481-491.
21. Cox A.J., Pyne D.B., Saunders P.U., Fricker P.A. Oral administration of the probiotic Lactobacillus fermentum VRI-003 and mucosal immunity in endurance athletes. Br. J. Sports Med. 2010, 44(4):222-226.
22. Collet J.P., Ducruet T., Kramer M.S., Haggerty J., Floret D., Chomel J.J., et al. Stimulation of nonspecific immunity to reduce the risk of recurrent infections in children attending day-care centers. The Epicrèche Research Group. Pediatr. Infect. Dis. J. 1993, 12(8):648-652.
23. Faden H., Duffy L., Wasielewski R., Wolf J., Krystofik D., Tung Y. Relationship between nasopharyngeal colonization and the development of otitis media in children Tonawanda/Williamsville Pediatrics. J. Infect. Dis. 1997, 175(6):1440-1445.
24. Glück U., Gebbers J.O. Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus, Streptococcus pneumoniae, and beta-hemolytic streptococci). Am. J. Clin. Nutr. 2003, 77(2):517-520.
25. Sanders M.E., Akkermans L.M., Haller D., Hammerman C., Heimbach J., Hörmannsperger G., et al. Safety assessment of probiotics for human use. Gut Microbes 2010, 1(3):164-185.
26. Whelan K., Myers C.E. Safety of probiotics in patients receiving nutritional support: a systematic review of case reports, randomized controlled trials, and nonrandomized trials. Am. J. Clin. Nutr. 2010, 91(3):687-703.
27. Salminen M.K., Tynkkynen S., Rautelin H., Saxelin M., Vaara M., Ruutu P., et al. Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin. Infect. Dis. 2002, 35:1155-1160.
28. Bernardeau M., Guguen M., Vernoux J.P. Beneficial lactobacilli in food and feed: long-term use, biodiversity and proposals for specific and realistic safety assessments. FEMS Microbiol. Rev. 2006, 30(4):487-513.
29. Gupta V., Garg R. Probiotics. Indian J. Med. Microbiol. 2009, 27(3):202-209.